These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

258 related items for PubMed ID: 29486578

  • 1. Scorpion inhibits epithelial-mesenchymal transition and metastasis of hepatocellular carcinoma.
    Yan YQ, Xie J, Wang JF, Shi ZF, Zhang X, Du YP, Zhao XC.
    Exp Biol Med (Maywood); 2018 Apr; 243(7):645-654. PubMed ID: 29486578
    [Abstract] [Full Text] [Related]

  • 2. All-trans retinoic acid inhibits proliferation, migration, invasion and induces differentiation of hepa1-6 cells through reversing EMT in vitro.
    Cui J, Gong M, He Y, Li Q, He T, Bi Y.
    Int J Oncol; 2016 Jan; 48(1):349-57. PubMed ID: 26548461
    [Abstract] [Full Text] [Related]

  • 3. FoxM1 overexpression promotes epithelial-mesenchymal transition and metastasis of hepatocellular carcinoma.
    Meng FD, Wei JC, Qu K, Wang ZX, Wu QF, Tai MH, Liu HC, Zhang RY, Liu C.
    World J Gastroenterol; 2015 Jan 07; 21(1):196-213. PubMed ID: 25574092
    [Abstract] [Full Text] [Related]

  • 4. Ventilagolin Suppresses Migration, Invasion and Epithelial-Mesenchymal Transition of Hepatocellular Carcinoma Cells by Downregulating Pim-1.
    Liu Y, Cheng DH, Lai KD, Su H, Lu GS, Wang L, Lv JH.
    Drug Des Devel Ther; 2021 Jan 07; 15():4885-4899. PubMed ID: 34880599
    [Abstract] [Full Text] [Related]

  • 5. Cetylpyridinium chloride inhibits hepatocellular carcinoma growth and metastasis through regulating epithelial-mesenchymal transition and apoptosis.
    Cai K, Fang Y, Zhang Y, Liu J, Ye Q, Ding L, Cai X.
    PLoS One; 2024 Jan 07; 19(9):e0310391. PubMed ID: 39302935
    [Abstract] [Full Text] [Related]

  • 6. ZnAs@SiO2 nanoparticles as a potential anti-tumor drug for targeting stemness and epithelial-mesenchymal transition in hepatocellular carcinoma via SHP-1/JAK2/STAT3 signaling.
    Huang Y, Zhou B, Luo H, Mao J, Huang Y, Zhang K, Mei C, Yan Y, Jin H, Gao J, Su Z, Pang P, Li D, Shan H.
    Theranostics; 2019 Jan 07; 9(15):4391-4408. PubMed ID: 31285768
    [Abstract] [Full Text] [Related]

  • 7. The anti-tumor activities of Neferine on cell invasion and oxaliplatin sensitivity regulated by EMT via Snail signaling in hepatocellular carcinoma.
    Deng G, Zeng S, Ma J, Zhang Y, Qu Y, Han Y, Yin L, Cai C, Guo C, Shen H.
    Sci Rep; 2017 Jan 30; 7():41616. PubMed ID: 28134289
    [Abstract] [Full Text] [Related]

  • 8. Novel ADAM-17 inhibitor ZLDI-8 inhibits the metastasis of hepatocellular carcinoma by reversing epithelial-mesenchymal transition in vitro and in vivo.
    Lu HY, Chu HX, Tan YX, Qin XC, Liu MY, Li JD, Ren TS, Zhang YS, Zhao QC.
    Life Sci; 2020 Mar 01; 244():117343. PubMed ID: 31978449
    [Abstract] [Full Text] [Related]

  • 9. Basil polysaccharide inhibits hypoxia-induced hepatocellular carcinoma metastasis and progression through suppression of HIF-1α-mediated epithelial-mesenchymal transition.
    Feng B, Zhu Y, Sun C, Su Z, Tang L, Li C, Zheng G.
    Int J Biol Macromol; 2019 Sep 15; 137():32-44. PubMed ID: 31252022
    [Abstract] [Full Text] [Related]

  • 10. Jianpi Huayu decoction inhibits the epithelial-mesenchymal transition of hepatocellular carcinoma cells by suppressing exosomal miR-23a-3p/Smad signaling.
    Xie CF, Feng KL, Wang JN, Luo R, Fang CK, Zhang Y, Shen CP, Zhong C.
    J Ethnopharmacol; 2022 Aug 10; 294():115360. PubMed ID: 35568116
    [Abstract] [Full Text] [Related]

  • 11. Puerarin inhibits hepatocellular carcinoma invasion and metastasis through miR-21-mediated PTEN/AKT signaling to suppress the epithelial-mesenchymal transition.
    Zhou Y, Xue R, Wang J, Ren H.
    Braz J Med Biol Res; 2020 Aug 10; 53(4):e8882. PubMed ID: 32294699
    [Abstract] [Full Text] [Related]

  • 12. Sorafenib suppresses the epithelial-mesenchymal transition of hepatocellular carcinoma cells after insufficient radiofrequency ablation.
    Dong S, Kong J, Kong F, Kong J, Gao J, Ji L, Pan B, Chen L, Zheng L, Sun W.
    BMC Cancer; 2015 Nov 30; 15():939. PubMed ID: 26620566
    [Abstract] [Full Text] [Related]

  • 13. Nutlin-3 reverses the epithelial-mesenchymal transition in gemcitabine-resistant hepatocellular carcinoma cells.
    Wu Q, Wang X, Liu J, Zheng J, Liu Y, Li Y, Su F, Ou W, Wang R.
    Oncol Rep; 2016 Sep 30; 36(3):1325-32. PubMed ID: 27430152
    [Abstract] [Full Text] [Related]

  • 14. Mannose-mediated inhibitory effects of PA-MSHA on invasion and metastasis of hepatocellular carcinoma via EGFR/Akt/IκBβ/NF-κB pathway.
    Li T, Dong ZR, Guo ZY, Wang CH, Zhi XT, Zhou JW, Li DK, Chen ZT, Chen ZQ, Hu SY.
    Liver Int; 2015 Apr 30; 35(4):1416-29. PubMed ID: 25066210
    [Abstract] [Full Text] [Related]

  • 15. Increased expression of SLC46A3 to oppose the progression of hepatocellular carcinoma and its effect on sorafenib therapy.
    Zhao Q, Zheng B, Meng S, Xu Y, Guo J, Chen LJ, Xiao J, Zhang W, Tan ZR, Tang J, Chen L, Chen Y.
    Biomed Pharmacother; 2019 Jun 30; 114():108864. PubMed ID: 30981107
    [Abstract] [Full Text] [Related]

  • 16. Tunicamycin inhibits cell proliferation and migration in hepatocellular carcinoma through suppression of CD44s and the ERK1/2 pathway.
    Hou H, Ge C, Sun H, Li H, Li J, Tian H.
    Cancer Sci; 2018 Apr 30; 109(4):1088-1100. PubMed ID: 29377347
    [Abstract] [Full Text] [Related]

  • 17. Actinidia chinensis Planch root extract attenuates proliferation and metastasis of hepatocellular carcinoma by inhibiting epithelial-mesenchymal transition.
    Fang T, Fang Y, Xu X, He M, Zhao Z, Huang P, Yuan F, Guo M, Yang B, Xia J.
    J Ethnopharmacol; 2019 Mar 01; 231():474-485. PubMed ID: 30415058
    [Abstract] [Full Text] [Related]

  • 18. Regorafenib inhibits migration, invasion, and vasculogenic mimicry of hepatocellular carcinoma via targeting ID1-mediated EMT.
    Zhang N, Zhang S, Wu W, Lu W, Jiang M, Zheng N, Huang J, Wang L, Liu H, Zheng M, Wang J.
    Mol Carcinog; 2021 Feb 01; 60(2):151-163. PubMed ID: 33428809
    [Abstract] [Full Text] [Related]

  • 19. Pin1 inhibition reverses the acquired resistance of human hepatocellular carcinoma cells to Regorafenib via the Gli1/Snail/E-cadherin pathway.
    Wang J, Zhang N, Han Q, Lu W, Wang L, Yang D, Zheng M, Zhang Z, Liu H, Lee TH, Zhou XZ, Lu KP.
    Cancer Lett; 2019 Mar 01; 444():82-93. PubMed ID: 30583078
    [Abstract] [Full Text] [Related]

  • 20. PHF8 upregulation contributes to autophagic degradation of E-cadherin, epithelial-mesenchymal transition and metastasis in hepatocellular carcinoma.
    Zhou W, Gong L, Wu Q, Xing C, Wei B, Chen T, Zhou Y, Yin S, Jiang B, Xie H, Zhou L, Zheng S.
    J Exp Clin Cancer Res; 2018 Sep 04; 37(1):215. PubMed ID: 30180906
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 13.